What is EKF Diagnostics Holdings plc (EKF.L)?

EKF Diagnostics Holdings plc (EKF.L) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

EKF Diagnostics Holdings plc (EKF.L)

Stock analysis · LSE · Healthcare · Medical - Devices

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.51

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

EKF Diagnostics Holdings plc (EKF.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Sep 15, 2026

EPS $0.01 vs est. $0.01

Missed by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc, a company founded in 1990 and based in Cardiff, United Kingdom, operates as an international supplier of diagnostic solutions. The firm excels in the development, manufacturing, and distribution of a wide array of diagnostic instruments, chemical reagents, and associated products. Its extensive market reach spans across Europe, the Middle East, the Americas, Asia, Africa, and beyond. The company's product lineup addresses various critical diagnostic needs. This includes a range of hemoglobin analysis devices, such as the handheld DiaSpect Tm and the quantitative Hemo Control. EKF also provides advanced glucose and lactate analyzers like the Biosen C-Line series, alongside point-of-care solutions for diabetes management, exemplified by the Quo-Lab A1c and Quo-Test A1c. Beyond these, their offerings extend to specialized diagnostic tools: the Creamatocrit Plus for assessing lipid concentration in mothers' milk, QuPID and True20 pregnancy tests, and the STAT-Site M Beta-hydroxybutyrate analyzer. EKF further supplies a comprehensive suite of clinical chemical analyzers and reagents, designed for monitoring conditions such as ketosis, glycated albumin, gly…